NeuroSense’s ALS drug PrimeC shows success in phase 2b, eyes final trial
PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
Pharmabiz8h
ProMIS Neurosciences begins patient dosing in phase 1b PRECISE-AD trial of PMN310 for Alzheimer’s disease
Massachusetts, Cambridge Saturday, March 1, 2025, 18:00 Hrs [IST] ...
Measles cases in western Texas rise to 146, possibly spreading to other areas
The number of confirmed measles cases in western Texas grew to 146, and it is possibly spreading to the central part of the ...
Farewell to glorious singer Roberta Flack
Roberta Flack, one of the top recording artists of the late 20th Century, has passed away at the age of 88. read ...
When this professor got cancer, he didn’t quit. He taught a class about it
When Bryant Lin, who teaches medicine at Stanford University, was given a terminal diagnosis, he wanted his students to understand the humanity at the core of medicine.
440 Shares in argenx SE (NASDAQ:ARGX) Bought by Ieq Capital LLC
Ieq Capital LLC bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) during the fourth quarter, according to the ...
The Canadian Press on MSN13h
Today-History-Mar01
Today in History for March 1: ...
MediciNova (NASDAQ:MNOV) Coverage Initiated at StockNews.com
Analysts at StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s ...